Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
IJID Regions|July 24, 2024
Prospective cohort study of patient demographics, viral agents, seasonality, and outcomes of influenza-like illness in Mexico in the late H1N1-pandemic and post-pandemic years (2010-2014)Arturo Galindo-Fraga, Paola Del Carmen Guerra-de-Blas, Ana A Ortiz-Hernández, et al.
Influenza and Other Respiratory Viruses|August 24, 2018
"Differential risk of hospitalization among single virus infections causing influenza-like illnesses"Ana A Ortiz-Hernández, Katherine K Nishimura, Daniel E Noyola, et al.
The Lancet. Infectious Diseases|December 22, 2006
WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virusHolger J Schünemann, Suzanne R Hill, Meetali Kakad, et al.
Frontiers in Neurology|April 8, 2021
Comparison of the Impact of Zika and Dengue Virus Infection, and Other Acute Illnesses of Unidentified Origin on Cognitive Functions in a Prospective Cohort in Chiapas MexicoPablo F Belaunzarán-Zamudio, Ana M Ortega-Villa, Alberto J Mimenza-Alvarado, et al.
The Journal of Infectious Diseases|April 24, 2024
SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to RemdesivirKanal Singh, Kevin Rubenstein, Viviane Callier, et al.
Lancet Regional Health. Americas|January 8, 2024
Clinical and molecular characterization of children and adults with respiratory bocavirus infection in Mexico: a cross-sectional nested study within the ILI002 prospective observational studyAna Estela Gamiño-Arroyo, José Arellano-Galindo, Paola Del Carmen Guerra-de-Blas, et al.
Research Square|May 13, 2022
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine - An Interim AnalysisEvan Anderson, Lisa Jackson, Nadine Rouphael, et al.
Medrxiv : the Preprint Server for Health Sciences|December 21, 2021
Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron NeutralizationNicole A Doria-Rose, Xiaoying Shen, Stephen D Schmidt, et al.
Research Square|May 19, 2023
Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) TrialAngela Branche, Nadine Rouphael, David Diemert, et al.
Pageof 2